14 Liraglutide and semaglutide, originally developed for people with Type 2 diabetes mellitus (T2DM), are approved for chronic weight management in people with obesity (or overweight and 1 weight-related comorbidities
If you spend too much time looking at these products, all of these terms start to blur together
I was surprised by the number of steps included and how involved it ended up being
One large retrospective cohort found that GLP-1 agonist use was associated with a lower risk of pancreatic cancer compared to treatment with other antihyperglycemic drugs, particularly insulin

the medication enhances, not replaces, these changes Genetics: Differences in receptor response mean some patients naturally respond better to one treatment than the other Starting weight: Higher BMI often leads to greater weight loss in kilograms, though percentage loss is similar Other medications: Certain drugs can reduce effectiveness by counteracting appetite suppression Difference Between Mounjaro and Wegovy: Side Effects Side effects are a key factor when choosing between Mounjaro and Wegovy, as tolerability affects adherence and outcomes Common side effects (both): Nausea Vomiting Diarrhoea Constipation Most noticeable during early dose escalation In the SURMOUNT-5 trial, Discontinuation due to side effects was lower with tirzepatide (2.7%) Individual response varies: Some patients tolerate Wegovy better Others find Mounjaro easier to manage No reliable way to predict tolerance in advance Important practical difference: Mounjaro may reduce the absorption of oral medications during dose increases This includes the combined oral contraceptive pill Additional contraceptive precautions are recommended for 4 weeks after each dose escalation Mounjaro vs Wegovy UK: Which Should You Choose

just dont eat it